Menu
Login
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
Post X-waiver: Improving Buprenorphine Access at the Community Pharmacy
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
4000 Wellness Drive
Midland, MI 48670
General Information
Active Dates
Thursday, September 14, 2023 - Monday, September 14, 2026
Estimated Completion Time
60 minutes
Conference Host
MidMichigan Health
Conference Location
Virtual Conference Room
Conference Name
Opioid Pain & Symptom Management
Provider
MyMichigan Health
Watch this Lecture Remotely
Objectives
Event Objectives
Relate the effect of the Mainstreaming Addiction Treatment Act and the DEA 30-day post teleprescribing rule on buprenorphine access, nationally and in Michigan.
Describe common barriers encountered by patients and pharmacists when filling buprenorphine prescriptions for OUD.
Identify specific strategies for resolving pharmacy-level barriers to buprenorphine access, including interprofessional collaboration and patient communication.
Presentations and Speakers
Presentation #1
Post X-waiver: Improving Buprenorphine Access at the Community Pharmacy
Vicki Tutag-Lehr, PharmD
Available Credits/Points
Credit Designation
MyMichigan Health designates this enduring material for a maximum of 1
AMA PRA Category 1 Credit
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MyMichigan Health designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
Event Disclosures
Speakers:
Victoria Tutag-Lehr, PharmD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Victoria Tutag-Lehr, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Doses of buprenorphine exceeding FDA daily maximum for OUD
Accreditation Statement
MyMichigan Health is accredited by The Michigan State Medical Society to provide continuing medical education for physicians.
Test Information
Percentage of Responses Required to Submit
100 %
Last Review Date
2/29/2024
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement